![Event_OCT-west](https://www.agilexbiolabs.com/wp-content/uploads/2023/11/Event_OCT-west.jpg)
![Event_CTF-2024](https://www.agilexbiolabs.com/wp-content/uploads/2023/11/Event_CTF-2024.jpg)
Our scientists and world-class technology deliver data that is globally accepted.
With years of experience, since 1996, in performing regulated bioanalysis, including quality method development, method validation and sample analysis services, we have successfully supported hundreds of preclinical and clinical trials around the world.
Our FDA-inspected Australian bioanalytical facilities have OECD GLP recognition with NATA and ISO 17025 Accreditation with NATA. Technical work is performed to meet FDA and EMA guidelines, providing our clients with a globally accepted basis for drug approval. Our global client base includes the leading pharmaceutical and biotech companies in Asia, Europe and the USA.
When you partner with Agilex Biolabs, you can be confident that your project will be delivered by the experts on time and with the highest quality results.
Our clients come from around the world to conduct their clinical research in Australia which not only offers some of the most highly regarded medical research, but they can also access up to 43.5% rebate on clinical trial spend including bioanalytical services.
THE APAC BIOLABS SPECIALISTS BASED IN AUSTRALIA
Our experience spans decades which means we have deep understanding and knowledge of clinical trial bioanalytics across virtually all therapeutic areas. Increasingly we have seen more complex trials requiring the latest custom-built technology and the world’s best scientists.